2023
DOI: 10.1080/07391102.2023.2256878
|View full text |Cite
|
Sign up to set email alerts
|

Gene expression analysis reveals GRIN1, SYT1, and SYN2 as significant therapeutic targets and drug repurposing reveals lorazepam and lorediplon as potent inhibitors to manage Alzheimer’s disease

Premkumar T.,
Bhavana Katta,
Sajitha Lulu S.
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 92 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?